XBiotech, Inc. (XBIT)
2.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
XBiotech Price : 2.20 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 2.20 | 2.25 | 2.19 | 2.20 | 118606.0 |
| Sep 03, 2026 | 2.20 | 2.22 | 2.19 | 2.20 | 136190.0 |
| Sep 02, 2026 | 2.22 | 2.22 | 2.19 | 2.19 | 109028.0 |
| Sep 01, 2026 | 2.29 | 2.309 | 2.19 | 2.22 | 221171.0 |
| Aug 31, 2026 | 2.26 | 2.31 | 2.25 | 2.30 | 23052.00 |
| Aug 28, 2026 | 2.32 | 2.32 | 2.26 | 2.27 | 7073.00 |
| Aug 27, 2026 | 2.28 | 2.33 | 2.26 | 2.30 | 32783.00 |
| Aug 26, 2026 | 2.30 | 2.32 | 2.29 | 2.31 | 21900.00 |
| Aug 25, 2026 | 2.30 | 2.32 | 2.23 | 2.30 | 52245.00 |
| Aug 24, 2026 | 2.28 | 2.32 | 2.26 | 2.31 | 27779.00 |
| Aug 21, 2026 | 2.26 | 2.32 | 2.26 | 2.28 | 11043.00 |
| Aug 20, 2026 | 2.30 | 2.33 | 2.26 | 2.31 | 10039.00 |
| Aug 19, 2026 | 2.315 | 2.32 | 2.25 | 2.31 | 41578.00 |
| Aug 18, 2026 | 2.32 | 2.345 | 2.25 | 2.27 | 45392.00 |
| Aug 17, 2026 | 2.31 | 2.36 | 2.29 | 2.31 | 15393.00 |
| Aug 14, 2026 | 2.335 | 2.37 | 2.30 | 2.30 | 46499.00 |
| Aug 13, 2026 | 2.44 | 2.47 | 2.307 | 2.33 | 41684.00 |
| Aug 12, 2026 | 2.35 | 2.46 | 2.29 | 2.46 | 58616.00 |
| Aug 11, 2026 | 2.28 | 2.35 | 2.25 | 2.33 | 22448.00 |
| Aug 10, 2026 | 2.27 | 2.295 | 2.27 | 2.28 | 4592.00 |
| Aug 07, 2026 | 2.27 | 2.29 | 2.27 | 2.27 | 15353.00 |
| Aug 06, 2026 | 2.28 | 2.28 | 2.255 | 2.28 | 9962.00 |
| Aug 05, 2026 | 2.26 | 2.28 | 2.23 | 2.26 | 35316.00 |
| Aug 04, 2026 | 2.24 | 2.29 | 2.23 | 2.24 | 28411.00 |
| Aug 03, 2026 | 2.220 | 2.25 | 2.22 | 2.235 | 12825.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.19 |
Price Related Metrics
| PEG Ratio | -0.0247 |
| Price to Book Value | 0.5221 |
| Earnings Yield | -67.30% |
| Market Cap | 67.07M |
| PEGY Ratio | -0.0247 |